Abstract:BackgroundDystrophin (DMD) gene mutations can affect muscular dystrophin isoform expression and result in progressive muscular dystrophy including Duchenne and Becker muscular dystrophies (DMD and BMD). To establish the correlation between phenotype and genotype and exemplify the current and future treatment for muscular dystrophy disorders, we investigated 20 patients suffering from a dystrophinopathy and summarized clinical manifestation and gene mutations of them. MethodsThe clinical manifestations, physical examination, laboratory work, and gene mutation results were collected in 20 patients with DMD or BMD diagnosed by clinical phenotype and genetic sequencing from July 2015 to December 2019. Multiplex ligation probe amplification (MLPA) and next-generation sequencing (NGS) were used to detect mutations in the DMD gene, and detected mutations were confirmed by Sanger sequencing. ResultsThe clinical manifestation of patients was characterized by progressive symmetrical muscle degeneration, limb weakness, and pseudohypertrophy along with the elevated concentration of creatine kinase, alanine aminotransferase, and aspartate aminotransferase. We found 11 dystrophin gene deletions (55%) and 4 duplication mutations (20%) among the affected patients. However, we also found point mutations including 1 nonsense (20%), 3 frameshifts (60%), and 1 splice sites (20%) mutations in the rest 5 patients. Among the 15 cases of exon deletion or duplication mutations, 7 were inherited from the mother, 3 were de-novo, while the other 5 were not tested. Besides, all 5 point-mutation cases were inherited from the mother, among which 4 point mutations were identified for the first time and linked to the disease phenotype. ConclusionsWe provided clinical portraits, genetic results, and the molecular effects of mutations in patients. Four novel point mutations were identified for the first time and associated with the development of DMD and BMD. Further, we expanded knowledge of the DMD variant spectrum and exemplified the emerging therapies in muscular dystrophy.

Advances in Diagnosis and Treatment of Limb-Girdle Muscular Dystrophy

Clinical Features and Molecular Genetic Analysis of a Pedigree of Limb Girdle Muscular Dystrophy

The Limb-Girdle Muscular Dystrophies

A Journey with LGMD: From Protein Abnormalities to Patient Impact

Research Progress on Disease Models and Gene Therapy of Duchenne Muscular Dystrophy

[Progress of Clinical and Genetic Research on Distal Hereditary Motor Neuropathy].

Clinical, Myopathological and Genetic Mutations Features of Limb Girdle Muscular Dystrophy 2I

Clinical and electrophysiological analysis of limb-girdle muscular dystrophy:A geneological report

Expert panel curation of 31 genes in relation to limb girdle muscular dystrophy

Genetic and Clinical Advances of Congenital Muscular Dystrophy.

Novel Mutations in the C-terminal Region of GMPPB Causing Limb-Girdle Muscular Dystrophy Overlapping with Congenital Myasthenic Syndrome

Novel compound heterozygous mutations of LAMA2-limb–girdle muscular dystrophy: A case report and literature review

Clinical spectrum and genetic variations of <i>LMNA</i>-related muscular dystrophies in a large cohort of Chinese patients

Limb-girdle Muscular Dystrophy Type 2D: Clinical and Genetic Analysis of a Family

Limb Girdle Muscular Dystrophy 23 Caused by Compound Heterozygous Mutations of LAMA2 Gene

Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing

Genetic Variation Analysis and Treatment Strategy of 20 Patients with Dystrophin Gene Mutations

First familial limb-girdle muscular dystrophy 2L in China: Clinical, imaging, pathological, and genetic features.

The Clinical,pathological Features and Analysis of Mitochondrial DNA Mutation in 8 Cases with Limb-Girdle Mitochon-Drial Myopathy

Diagnosis and Therapeutic Possibilities

Limb-Girdle Congenital Myasthenic Syndrome in A Chinese Family with Novel Mutations in Musk Gene and Literature Review